HGF/c‐MET pathway contributes to cisplatin‐mediated PD‐L1 expression in hepatocellular carcinoma

LncRNA BANCR Attenuates the Killing Capacity of Cisplatin on Gastric Cancer Cell Through the ERK1/2 Pathway

(2021) Xiang Miao et al.   Cancer Management and Research

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

(2021) Deborah Blythe Doroshow et al.   Nature Reviews Clinical Oncology

BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism

(2021) Lifang Luo et al.   Cell Death & Disease

PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression

(2021) Lijun Wu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance

(2020) Isabella Giacomini et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Clinical Challenges of Immune Checkpoint Inhibitors

(2020) Maria de Miguel et al.   CANCER CELL

Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1

(2020) Shenghao Li et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion

(2020) Linyong Du et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro

(2020) Jianfei Xu et al.   LIFE SCIENCES

KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC

(2020) Chunxia Cheng et al.   Cancer Management and Research

Systemic treatment of HCC in special populations

(2020) Lorenza Rimassa et al.   JOURNAL OF HEPATOLOGY

Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3/-catenin signaling pathway

(2019) Shi-Yuan Wen et al.   PHYTOMEDICINE

Inhibition of PI3K/mTOR increased the sensitivity of hepatocellular carcinoma cells to cisplatin via interference with mitochondrial‐lysosomal crosstalk

(2019) Jiyao Sheng et al.   CELL PROLIFERATION

Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation

(2019) Hongda Ding et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Cisplatin contributes to programmed death-ligand 1 (PD-L1) expression in bladder cancer through ERK1/2 - AP-1 signaling pathway

(2019) Te-Fu Tsai et al.   BIOSCIENCE REPORTS

Cisplatin-Induced Ototoxicity: Updates on Molecular Targets

(2019) Erica Gentilin et al.   TRENDS IN MOLECULAR MEDICINE

Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer

(2019) Ludovic Fournel et al.   CANCER LETTERS

EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression

(2019) Shunli Peng et al.   Molecular Cancer

The role of microRNA in the resistance to treatment of hepatocellular carcinoma

(2019) Muhammad Yogi Pratama et al.   Annals of Translational Medicine

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

(2018) Ming Yi et al.   Molecular Cancer

Recent advances in medical management of hepatocellular carcinoma

(2018) Kenji Ikeda   HEPATOLOGY RESEARCH

Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition

(2017) Yei-San Hsieh et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma

(2017) Eleanna Papa et al.   Cell Death & Disease

PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome

(2017) Hashem O. Alsaab et al.   Frontiers in Pharmacology

HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment

(2016) Stefan Hartmann et al.   CLINICAL CANCER RESEARCH

The hepatocyte growth factor (HGF)–MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions

(2016) Subburaj Ilangumaran et al.   CYTOKINE

Hepatocyte growth factor: A regulator of inflammation and autoimmunity

(2015) Nicolas Molnarfi et al.   AUTOIMMUNITY REVIEWS

Hepatocyte growth factor and Met in drug discovery

(2015) K. Sakai et al.   JOURNAL OF BIOCHEMISTRY

Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge

(2015) Wasia Rizwani et al.   Cancers

Wnt signaling and hepatocarcinogenesis: Molecular targets for the development of innovative anticancer drugs

(2013) Floriane Pez et al.   JOURNAL OF HEPATOLOGY

Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma

(2013) Guofeng Yu et al.   PLoS One

Wnt/β-catenin signalling in prostate cancer

(2012) Robert M. Kypta et al.   Nature Reviews Urology

Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans

(2011) Yeonghwan Kim et al.   HEPATOLOGY

Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma

(2009) Anupam Bishayee et al.   CANCER TREATMENT REVIEWS

TGF-β1 targets the GSK-3β/β-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts

(2008) F CARACI et al.   PHARMACOLOGICAL RESEARCH

HGF Increases Cisplatin Resistance via Down-Regulation of AIF in Lung Cancer Cells

(2007) Jin-Tang Chen et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY